Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

HKG:2190 Revenue

Zylox-Tonbridge Medical Technology had revenue of 632.04M CNY in the half year ending June 30, 2026, with 72.69% growth. This brings the company's revenue in the last twelve months to 1.21B, up 34.40% year-over-year. In the year 2025, Zylox-Tonbridge Medical Technology had annual revenue of 1.06B with 35.15% growth.

• Revenue (ttm): 1.21B CNY
• Revenue Growth: +34.40%
• P/S Ratio: 4.84
• Revenue / Employee: 994.69K CNY
• Employees: 1,214
• Market Cap: 6.75B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.06B	275.01M	35.15%
Dec 31, 2024	782.48M	254.72M	48.27%
Dec 31, 2023	527.75M	193.66M	57.97%
Dec 31, 2022	334.09M	156.18M	87.78%
Dec 31, 2021	177.91M	150.28M	543.89%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error